Pfizer CRZ 250 (Xalkori 250 mg)
Generic Name: crizotinib
Pill imprint Pfizer CRZ 250 has been identified as Xalkori 250 mg.
Xalkori is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Xalkori 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for Pfizer CRZ 250 (Xalkori 250 mg)
Xalkori
- Generic Name:
- crizotinib
- Imprint:
-
Pfizer
CRZ 250 - Strength:
- 250 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Pfizer Inc.
More resources
Xalkori is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
